
KCAS Bio is thrilled to announce our participation in the 28th Annual Meeting of the American Society of Cell & Gene Therapy (ASGCT), taking place from May 13th to May 17th, 2025, in New Orleans, Louisiana. This event serves as a global hub for scientific discovery and collaboration, bringing together…

KCAS Bio is excited to announce our participation in the American Association of Pharmaceutical Scientists National Biotechnology Conference (AAPS NBC), taking place from May 4th to May 7th, 2025, in Boston, Massachusetts. This premier event serves as a meeting ground for thought leaders, researchers, and industry professionals dedicated to the…

KCAS Bio is thrilled to participate in the 2025 MetroFlow Cytometry Vendor Day, taking place on April 10th at Regeneron Pharmaceuticals in Tarrytown, New York. This exciting event is a hub for scientific innovation, bringing together leaders in the field of flow cytometry to discuss emerging trends, cutting-edge technologies, and…

KCAS Bio is proud to announce our attendance at AD/PD 2025, Advances in Science & Therapy, taking place in Vienna, Austria, from April 1-5, 2025. This globally recognized conference brings together leading researchers, clinicians, and industry professionals to address the challenges of Alzheimer’s Disease (AD), Parkinson’s Disease (PD), and related…

KCAS Bio is excited to announce our participation in the Boston Society Gene and Cell Therapy Conference, taking place in Cambridge, Massachusetts, on March 20-21, 2025. This premier event gathers leading experts, innovators, and researchers to explore the latest advancements in gene and cell therapy. We are proud to contribute…

KCAS Bio is delighted to announce our participation in the 15th Annual World ADC, taking place in London, United Kingdom, from March 3-6, 2025. This premier event brings together the brightest minds in the field of antibody-drug conjugates (ADCs) to explore the latest scientific advancements, strategies, and technologies shaping the…

KCAS Bio is excited to announce our attendance at the 16th Open Scientific EIP (European Immunogenicity Platform) Symposium, taking place in Lisbon, Portugal, from February 24-26, 2025. This premier event brings together global leaders in immunogenicity to share insights, exchange ideas, and drive innovation in the development of biologics and…

KCAS Bio is proud to announce our participation in the 20th Congress of ECCO (European Crohn’s and Colitis Organisation), taking place in Berlin, Germany, from February 19-22, 2025. This prestigious event brings together global experts, researchers, and clinicians dedicated to improving the understanding and treatment of inflammatory bowel diseases (IBD).

KCAS Bio is excited to announce our participation in the Society of Toxicology (SOT) Annual Meeting and ToxExpo, taking place in Orlando, Florida on March 16th-20th. As one of the largest gatherings of toxicologists and life sciences professionals, this event offers a unique platform to connect with leaders in toxicology…

Biomarker assay development is pivotal to clinical research and the success of a study, yet the journey from qualification to validation is often complex. In this blog, we discuss four must-know essentials to optimize your assay development process. 1. Understand the Context of Use: Qualification vs. Validation The FDA emphasizes…

Dose Formulation Analysis is an essential step in regulated nonclinical studies. Robust analytical methods, rapid turnaround, and efficient communication helps ensure the dose form results for your GLP studies are delivered on time. At KCAS Bio, our scientific expertise allows us to develop methods that achieve…

In episode 84 of “The Weekly Bioanalysis”, our special guest, Bryan Parmentier, joins Dom and John to discuss his background and current role at KCAS Bio, offering insights into the field of small molecule method development. He delves into the typical challenges encountered when working with LC-MS analytes, and how…